EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY 4.0

Narrowband ultraviolet B phototherapy for pityriasis lichenoides: A real‐life experience

Esra Agaoglu iD, Hilal Kaya Erdogan iD, Ersoy Acer iD, Zeynep Nurhan Saracoglu iD, Muzaffer Bilgin iD

Photodermatology, Photoimmunology & Photomedicine · 2023-09 · 39 (5) · 520-526

DOI: 10.1111/phpp.12895 ↗

At a glance

Beobachtungsstudie in Photodermatology, Photoimmunology & Photomedicine, published online on 2023-06-20. Written by Esra Agaoglu and 4 co-authors. Institution: Department of Dermatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey. Major MEDLINE topics: Pityriasis Lichenoides, Ultraviolet Therapy. Cited 8 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Pityriasis lichenoides (PL) is a papulosquamous disease affecting both children and adults, for which narrowband‐UVB (NB‐UVB) phototherapy is regarded as a commonly used treatment option. The aim of this study was to investigate the efficacy of NB‐UVB phototherapy in the management of PL and to compare response rates in pediatric and adult age groups. Materials and methods This observational, retrospective study included 20 PL patients (12 pityriasis lichenoides chronica; PLC, 8 pityriasis lichenoides et varioliformis acuta; PLEVA) who failed to respond to other treatment modalities. The data for this study were collected retrospectively from patient follow‐up forms in the phototherapy unit.

Results

A complete response (CR) was obtained in all pediatric patients with PL, while 53.8% of adult patients had achieved CR. The mean cumulative dose required to achieve the CR was higher in pediatric patients than adult patients with PL ( p < .05). The CR was achieved in 6 (75%) of 8 PLEVA patients, while 8 (66.7%) of 12 PLC patients had reached to CR. The mean number of exposures for patients with PLC to achieve a CR was higher than patients with PLEVA ( p < .05). Erythema was the most common adverse effect during phototherapy particularly in 5 (35.7%) of the patients with PL who had achieved CR.

Conclusions

NB‐UVB is an effective and well‐tolerated treatment option for PL especially in diffuse types. A higher response can be obtained in children with higher cumulative dose. Patients with PLC may require more exposures for CR than patients with PLEVA.

Subjects

MeSH terms (MEDLINE)

Pityriasis LichenoidesUltraviolet TherapyAdultHumansChildRetrospective StudiesPhototherapyUltraviolet Rays

Author keywords

Pityriasis lichenoidesadultchildrennarrow-band UVBphototherapy

Authors and institutions

  • Department of Dermatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Department of Biostatistics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

ORCID profiles: Esra Agaoglu, Hilal Kaya Erdogan, Ersoy Acer, Zeynep Nurhan Saracoglu, Muzaffer Bilgin

Cite

APA

Agaoglu, E., Erdogan, H. K., Acer, E., Saracoglu, Z. N., & Bilgin, M. (2023). Narrowband ultraviolet B phototherapy for pityriasis lichenoides: A real‐life experience. Photodermatology, Photoimmunology & Photomedicine, 39(5), 520-526. https://doi.org/10.1111/phpp.12895

Vancouver

Agaoglu E, Erdogan HK, Acer E, Saracoglu ZN, Bilgin M. Narrowband ultraviolet B phototherapy for pityriasis lichenoides: A real‐life experience. Photodermatology, Photoimmunology & Photomedicine. 2023;39(5):520-526. doi:10.1111/phpp.12895

BibTeX
@article{Agaoglu2023,
  author = {Agaoglu, Esra and Erdogan, Hilal Kaya and Acer, Ersoy and Saracoglu, Zeynep Nurhan and Bilgin, Muzaffer},
  title = {Narrowband ultraviolet B phototherapy for pityriasis lichenoides: A real‐life experience},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2023},
  volume = {39},
  number = {5},
  pages = {520--526},
  doi = {10.1111/phpp.12895}
}
Start for free →